SLDB

9.16

1.51% -0.14

Dopo l'orario di chiusura: 9.16

Solid Biosciences Inc (SLDB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SLDB Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$9.30

Aprire:

$9.28

Volume 24 ore:

1.11M

Relative Volume:

0.71

Capitalizzazione di mercato:

$982.18M

Reddito:

$14.79M

Utile/perdita netta:

$-191.78M

Rapporto P/E:

-4.7059

EPS:

-1.9465

Flusso di cassa netto:

$-172.86M

1 W Prestazione:

+0.66%

1M Prestazione:

+16.99%

6M Prestazione:

+48.22%

1 anno Prestazione:

+54.47%

Intervallo 1D:

$8.8604

$9.28

Intervallo di 1 settimana:

$8.81

$9.87

Portata 52W:

$3.79

$11.45

Solid Biosciences Inc Stock (SLDB) Company Profile

Nome

Solid Biosciences Inc

Settore

Healthcare (1033)

Industria

Biotechnology (582)

Telefono

617-337-4680

Indirizzo

500 RUTHERFORD AVENUE, CHARLESTOWN, MA

Dipendente

121

Cinguettio

@SolidBioDMD

Prossima data di guadagno

2026-08-11

Ultimi documenti SEC

SLDB's Discussions on Twitter

Compare SLDB vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SLDB Solid Biosciences Inc	9.16	975.75M	14.79M	-191.78M	-172.86M	-1.9465
VRTX Vertex Pharmaceuticals Inc	547.59	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	828.50	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,011.11	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.89	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	211.58	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-20	Iniziato	Guggenheim	Buy
2025-12-04	Iniziato	Needham	Buy
2025-06-26	Iniziato	Citigroup	Buy
2025-01-08	Iniziato	Truist	Buy
2024-12-13	Iniziato	Wedbush	Outperform
2024-12-10	Iniziato	JMP Securities	Mkt Outperform
2024-07-15	Aggiornamento	JP Morgan	Neutral → Overweight
2024-06-24	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-05-31	Ripresa	Piper Sandler	Overweight
2024-03-28	Iniziato	William Blair	Outperform
2024-03-15	Iniziato	Citigroup	Buy
2024-03-14	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-12-08	Iniziato	H.C. Wainwright	Buy
2021-07-12	Iniziato	Piper Sandler	Neutral
2021-05-27	Iniziato	Jefferies	Buy
2021-03-16	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-03-09	Iniziato	Barclays	Overweight
2021-01-08	Aggiornamento	Credit Suisse	Underperform → Neutral
2020-07-28	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-05-07	Downgrade	Evercore ISI	Outperform → In-line
2019-10-11	Iniziato	Evercore ISI	Outperform
2019-08-29	Downgrade	Citigroup	Neutral → Sell
2019-08-19	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2019-08-16	Aggiornamento	Chardan Capital Markets	Neutral → Buy
2019-05-14	Downgrade	Credit Suisse	Neutral → Underperform
2019-05-14	Downgrade	Goldman	Neutral → Sell
2019-02-08	Aggiornamento	Citigroup	Sell → Neutral
2019-02-08	Downgrade	SVB Leerink	Outperform → Mkt Perform
2018-11-06	Iniziato	Citigroup	Sell
2018-09-06	Iniziato	Credit Suisse	Neutral

Mostra tutto

Solid Biosciences Inc Borsa (SLDB) Ultime notizie

Aug 21, 2026

Solid Biosciences LLC (NASDAQ: SLDB) Share Price, SLDB Stock News, SLDB Share Price & Updates - Kalkine

Aug 21, 2026

SLDB Maintained by Truist Securities -- Price Target Raised to $20 - GuruFocus

Aug 21, 2026

Solid Biosciences (NASDAQ:SLDB) Earns Buy Rating from Analysts at Truist Financial - MarketBeat

Aug 21, 2026

Aug 20, 2026

Solid Biosciences (NASDAQ:SLDB) Stock Price Down 6.7%Time to Sell? - MarketBeat

Aug 20, 2026

Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Aug 20, 2026

Aug 14, 2026

Perceptive Advisors (NASDAQ: SLDB) details 11.2% beneficial stake and warrant limits - Stock Titan

Aug 14, 2026

Solid Biosciences (SLDB): Vestal Point Capital discloses 4.8% ownership, including warrant shares - Stock Titan

Aug 14, 2026

Solid Biosciences (SLDB) Holds Steady Near $9.09 as Gene Therapy Sector Watches Key LevelsVolume Weighted Price - vinanet.vn

Aug 14, 2026

Aug 12, 2026

HC Wainwright Has Positive Estimate for SLDB Q3 Earnings - MarketBeat

Aug 12, 2026

Aug 11, 2026

Form 8K Solid Biosciences LLC For: 6 August By Investing.com - Investing.com Nigeria

Aug 11, 2026

J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $11 - Moomoo

Aug 11, 2026

Dimensional Fund Advisors LP Acquires 277,051 Shares of Solid Biosciences Inc. $SLDB - MarketBeat

Aug 11, 2026

Aug 10, 2026

Solid Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 10, 2026

Citizens reiterates Solid Biosciences stock rating on pipeline progress By Investing.com - Investing.com Nigeria

Aug 10, 2026

Citizens reiterates Solid Biosciences stock rating on pipeline progress - Investing.com

Aug 10, 2026

Aug 08, 2026

Solid Biosciences (NASDAQ:SLDB) Posts Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat

Aug 08, 2026

Aug 07, 2026

Solid Biosciences Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

Aug 07, 2026

Solid Biosciences Inc. Stock 12‑Month Price Target Cut to $17.64, Implies 102% Upside - TradingView

Aug 07, 2026